Literature DB >> 23159745

First-trimester metabolomic detection of late-onset preeclampsia.

Ray O Bahado-Singh1, Ranjit Akolekar, Rupasri Mandal, Edison Dong, Jianguo Xia, Michael Kruger, David S Wishart, Kypros Nicolaides.   

Abstract

OBJECTIVE: We sought to identify first-trimester maternal serum biomarkers for the prediction of late-onset preeclampsia (PE) using metabolomic analysis. STUDY
DESIGN: In a case-control study, nuclear magnetic resonance-based metabolomic analysis was performed on first-trimester maternal serum between 11(+0)-13(+6) weeks of gestation. There were 30 cases of late-onset PE, i.e., requiring delivery ≥37 weeks, and 59 unaffected controls. The concentrations of 40 metabolites were compared between the 2 groups. We also compared 30 early-onset cases to the late-onset group.
RESULTS: A total of 14 metabolites were significantly elevated and 3 significantly reduced in first-trimester serum of late-onset PE patients. A complex model consisting of multiple metabolites and maternal demographic characteristics had a 76.6% sensitivity at 100% specificity for PE detection. A simplified model using fewer predictors yielded 60% sensitivity at 96.6% specificity. Strong separation of late- vs early-onset PE groups was achieved.
CONCLUSION: Significant differences in the first-trimester metabolites were noted in women who went on to developed late-onset PE and between early- and late-onset PE.
Copyright © 2013. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23159745     DOI: 10.1016/j.ajog.2012.11.003

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  30 in total

1.  Metabolomic prediction of endometrial cancer.

Authors:  Ray O Bahado-Singh; Amit Lugade; Jayson Field; Zaid Al-Wahab; BeomSoo Han; Rupasri Mandal; Trent C Bjorndahl; Onur Turkoglu; Stewart F Graham; David Wishart; Kunle Odunsi
Journal:  Metabolomics       Date:  2017-12-01       Impact factor: 4.290

Review 2.  First trimester screening for pre-eclampsia.

Authors:  Stefan C Kane
Journal:  Obstet Med       Date:  2016-05-14

Review 3.  High-Resolution Metabolomics: Review of the Field and Implications for Nursing Science and the Study of Preterm Birth.

Authors:  Shuzhao Li; Anne L Dunlop; Dean P Jones; Elizabeth J Corwin
Journal:  Biol Res Nurs       Date:  2015-07-16       Impact factor: 2.522

4.  Integration of metabolomic and transcriptomic networks in pregnant women reveals biological pathways and predictive signatures associated with preeclampsia.

Authors:  Rachel S Kelly; Damien C Croteau-Chonka; Amber Dahlin; Hooman Mirzakhani; Ann C Wu; Emily S Wan; Michael J McGeachie; Weiliang Qiu; Joanne E Sordillo; Amal Al-Garawi; Kathryn J Gray; Thomas F McElrath; Vincent J Carey; Clary B Clish; Augusto A Litonjua; Scott T Weiss; Jessica A Lasky-Su
Journal:  Metabolomics       Date:  2016-12-12       Impact factor: 4.290

5.  Applications of Metabolomics in the Study and Management of Preeclampsia; A Review of the Literature.

Authors:  Rachel S Kelly; Rachel T Giorgio; Bo L Chawes; Natalia I Palacios; Kathryn J Gray; Hoooman Mirzakhani; Ann Wu; Kevin Blighe; Scott T Weiss; Jessica Lasky-Su
Journal:  Metabolomics       Date:  2017-06-12       Impact factor: 4.290

6.  Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy Whitten; Adi L Tarca; Gaurav Bhatti; Sorin Draghici; Piya Chaemsaithong; Jezid Miranda; Sonia S Hassan
Journal:  J Perinat Med       Date:  2013-09-01       Impact factor: 1.901

Review 7.  Hypertension in Pregnancy: Defining Blood Pressure Goals and the Value of Biomarkers for Preeclampsia.

Authors:  Pitchaphon Nissaisorakarn; Sairah Sharif; Belinda Jim
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

8.  Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study.

Authors:  G S Moore; A A Allshouse; A L Post; H L Galan; K D Heyborne
Journal:  J Perinatol       Date:  2014-12-04       Impact factor: 2.521

Review 9.  Pre-eclampsia part 2: prediction, prevention and management.

Authors:  Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Steven J Korzeniewski; Lami Yeo; Roberto Romero
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

Review 10.  What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?

Authors:  Alba Gonzalez-Franquesa; Alison M Burkart; Elvira Isganaitis; Mary-Elizabeth Patti
Journal:  Curr Diab Rep       Date:  2016-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.